Literature DB >> 23295649

Angiostatin production increases in response to decreased nitric oxide in aging rat kidney.

Minoru Satoh1, Kengo Kidokoro, Masahito Ozeki, Hajime Nagasu, Yuko Nishi, Chieko Ihoriya, Sohachi Fujimoto, Tamaki Sasaki, Naoki Kashihara.   

Abstract

The development of interstitial fibrosis occurs with aging. Impaired angiogenesis, associated with progressive loss of the renal microvasculature, is thought to be a cause of age-related nephropathy. However, the mechanism of capillary loss in aging kidney has not been fully elucidated. Angiostatin is a kringle-containing fragment of plasminogen and is a potent inhibitor of angiogenesis in vivo. Whether angiostatin generation is increased in the aging kidney has not been investigated. We examined 4, 10, 16, and 24-month-old Sprague-Dawley rats for angiostatin production and found that angiostatin generation was increased in aged rats. The protein expression and the activity of cathepsin D-the enzyme for angiostatin production--were increased in aged rats. In the aging kidney, nitric oxide (NO) availability is decreased. To investigate the role of NO in angiostatin production, human umbilical vein endothelial cells were treated with L-NG-nitroarginine methyl ester (L-NAME). L-NAME-treated cells showed increased cathepsin D activity and angiostatin production. For in vivo experiments, 16- to 18-month-old rats were treated with L-NAME or molsidomine for 3 months. Angiostatin production was increased in L-NAME-treated kidney, accompanied by increased cathepsin D activity. In contrast, angiostatin production was decreased in molsidomine-treated kidney, accompanied by decreased cathepsin D activity. In conclusion, angiostatin generation by cathepsin D was increased in the aging rat kidney. Decreased NO production activated cathepsin D activity. Increased angiostatin production may be related to capillary loss and interstitial damage in the aging rat kidney.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295649     DOI: 10.1038/labinvest.2012.171

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

Review 1.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

2.  Aerobic Endurance Exercise Ameliorates Renal Vascular Sclerosis in Aged Mice by Regulating PI3K/AKT/mTOR Signaling Pathway.

Authors:  Chuncha Bao; Zhong Yang; Qian Li; Qiyan Cai; Hongli Li; Bin Shu
Journal:  DNA Cell Biol       Date:  2020-01-22       Impact factor: 3.311

3.  Incomplete Restoration of Angiotensin II-Induced Renal Extracellular Matrix Deposition and Inflammation Despite Complete Functional Recovery in Rats.

Authors:  Anne-Roos S Frenay; Saleh Yazdani; Miriam Boersema; Anne Marijn van der Graaf; Femke Waanders; Jacob van den Born; Gerjan J Navis; Harry van Goor
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

4.  Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression.

Authors:  Yuan-Yuan Xia; Ru Bu; Guang-Yan Cai; Xue-Guang Zhang; Shu-Wei Duan; Jie Wu; Di Wu; Xiang-Mei Chen
Journal:  BMC Nephrol       Date:  2019-04-03       Impact factor: 2.388

Review 5.  Ageing and microvasculature.

Authors:  Maria Giovanna Scioli; Alessandra Bielli; Gaetano Arcuri; Amedeo Ferlosio; Augusto Orlandi
Journal:  Vasc Cell       Date:  2014-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.